MENLO VENTURES MANAGEMENT L P
Q1 2026 Form 13-F

MENLO PARK, DELAWARE
CIK 0001911541 · CRD 283999 · Exempt reporting adviser
$326.9M Reported Value Total
Exempt Reporting Adviser
Source: Form ADV filed 2026-03-31
Reported value
$326.9M
Quarter over quarter
0.0%
Holdings
3
Top-10 concentration
100.0%

Key People

Named on the latest Form 13-F filing — not necessarily an owner
Venky Ganesan
Managing Member of General Partner

Filing Navigation

13F Metrics

Loading 13F Metrics

Q1 2026 13F record

Q1 2026 13F filing summary

Q1 2026 Form 13F portfolio summary
Period of report March 31, 2026
Filed May 15, 2026
Form 13F-HR
Reported value $326.9M
Positions 3
Change in reported value First reported quarter
Top-10 concentration 100.0%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 6, 2026
5 $240.6M
Q2 2026 13F
Filed Aug 10, 2026
3 $357.4M
Q1 2026 13F
Filed May 15, 2026
3 $326.9M

Top 3 holdings · Q1 2026

Largest Q1 2026 13F positions by reported value
# Holding Reported value % of portfolio
1 CHYM CHIME FINL INC $326.7M 99.95%
2 BRZE BRAZE INC $131.7K 0.04%
3 SNTI SENTI BIOSCIENCES INC $29.0K < 0.01%

Values as reported on the Q1 2026 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings